Research Overview

Dr. Kenney conducts clinical outcomes research focused on childhood cancer survivors. She is a principal investigator on the Childhood Cancer Survivors Study (CCSS) in the areas of second primary cancers and chronic disease. Dr Kenney is also the principal investigator on institutional clinical studies investigating male reproductive function, renal function, and gastrointestinal disease in childhood cancer survivors. Research interests also include investigating models of clinical services to address the ongoing medical needs of childhood cancer survivors.

 

Research Background

Dr. Kenney received her MD at the State University of New York, Stony Brook School of Medicine, completed her Pediatric residency at Children's National Medical Center, Washington, DC and a pediatric hematology/oncology fellowship at Children's National Medical Center, Washington, DC. Focus of Research The goal of Dr. Kenney's research is to reduce morbidity associated with treatment of cancer during childhood by understanding the spectrum of treatment associated late effects and designing interventions to improve long term outcomes for survivors.

 

Education

Undergraduate School

Boston College
1985 Boston MA

Medical School

SUNY at Stony Brook School of Medicine
1989 Stony Brook NY

Internship

Pediatrics Children's National Medical Center
1990 Washington DC

Residency

Pediatrics Children's National Medical Center
1992 Washington DC

Fellowship

Pediatric Hematology-Oncology Children's National Medical Center
1995 Washington DC

Publications

  1. Development and refinement of the Cardiovascular Health Equity through Food (CHEF) intervention for childhood cancer survivors. J Cancer Surviv. 2025 Jan 04. View Abstract
  2. Correction to: Cancer survivorship programs at the Dana-Farber Cancer Institute. J Cancer Surviv. 2024 Apr 12. View Abstract
  3. Cancer survivorship programs at the Dana-Farber Cancer Institute. J Cancer Surviv. 2024 02; 18(1):34-41. View Abstract
  4. REPLY: Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy. JACC CardioOncol. 2023 Feb; 5(1):157. View Abstract
  5. Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study (CCSS). JAMA Oncol. 2022 Oct 13. View Abstract
  6. Management of childhood cancer survivors at risk for thyroid function abnormalities: A Delphi study. Pediatr Blood Cancer. 2022 12; 69(12):e29942. View Abstract
  7. Consensus Recommendations for Managing Childhood Cancer Survivors at Risk for Stroke After Cranial Irradiation: A Delphi Study. Neurology. 2022 10 18; 99(16):e1755-e1766. View Abstract
  8. Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy. JACC CardioOncol. 2022 Sep; 4(3):354-367. View Abstract
  9. Randomized Waitlist-Control Trial of a Web-Based Stress-Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors: Protocol for the Bounce Back Study. JMIR Res Protoc. 2022 Jan 26; 11(1):e34033. View Abstract
  10. Early parental knowledge of late effect risks in children with cancer. Pediatr Blood Cancer. 2022 02; 69(2):e29473. View Abstract
  11. Virtual visits as long-term follow-up care for childhood cancer survivors: Patient and provider satisfaction during the COVID-19 pandemic. Pediatr Blood Cancer. 2021 06; 68(6):e28927. View Abstract
  12. Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021 02; 22(2):e45-e56. View Abstract
  13. Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021 02; 22(2):e57-e67. View Abstract
  14. Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021 02; 22(2):e68-e80. View Abstract
  15. Outcomes and implications of a single brain death examination policy on organ donation outcomes at a high-volume trauma center. J Trauma Acute Care Surg. 2020 12; 89(6):1166-1171. View Abstract
  16. Aortic Aneurysm Natural Progression is Not Influenced by Concomitant Malignancy and Chemotherapy. Ann Vasc Surg. 2021 Feb; 71:29-39. View Abstract
  17. Long-Term Psychosocial Well-Being and Quality of Life Among Childhood Cancer Survivors Who Developed a Subsequent Malignant Neoplasm. J Adolesc Young Adult Oncol. 2021 04; 10(2):240-245. View Abstract
  18. Regional practice norms for the care of childhood cancer survivors at risk for cardiomyopathy: A Delphi study. Pediatr Blood Cancer. 2019 09; 66(9):e27868. View Abstract
  19. The management of childhood cancer survivors at risk for stroke: A Delphi survey of regional experts. Pediatr Blood Cancer. 2018 12; 65(12):e27394. View Abstract
  20. Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research. J Clin Oncol. 2018 07 20; 36(21):2160-2168. View Abstract
  21. Barriers and facilitators to sexual and reproductive health communication between pediatric oncology clinicians and adolescent and young adult patients: The clinician perspective. Pediatr Blood Cancer. 2018 08; 65(8):e27087. View Abstract
  22. Understanding predictors of continued long-term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2017 Oct; 64(10). View Abstract
  23. Preparing childhood cancer survivors for transition to adult care: The young adult perspective. Pediatr Blood Cancer. 2017 Oct; 64(10). View Abstract
  24. Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Lancet Oncol. 2017 02; 18(2):e75-e90. View Abstract
  25. Transition and transfer of childhood cancer survivors to adult care: A national survey of pediatric oncologists. Pediatr Blood Cancer. 2017 02; 64(2):346-352. View Abstract
  26. Fertility preservation in children, adolescents, and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations. Cancer. 2016 Jul 15; 122(14):2216-23. View Abstract
  27. Fatigue in adolescent and adult survivors of non-CNS childhood cancer: a report from project REACH. Support Care Cancer. 2016 09; 24(9):3951-9. View Abstract
  28. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2016 05; 17(5):567-76. View Abstract
  29. Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2016 Mar 20; 34(9):910-8. View Abstract
  30. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014 Jul 20; 32(21):2217-23. View Abstract
  31. Impaired testicular function after an ifosfamide-containing regimen for pediatric osteosarcoma: a case series and review of the literature. J Pediatr Hematol Oncol. 2014 Apr; 36(3):237-40. View Abstract
  32. Transition and transfer of adolescents and young adults with pediatric onset chronic disease: the patient and parent perspective. J Pediatr Rehabil Med. 2014; 7(1):43-51. View Abstract
  33. Sexual function in childhood cancer survivors: a report from Project REACH. J Sex Med. 2013 Aug; 10(8):2084-93. View Abstract
  34. Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications. J Clin Oncol. 2013 Mar 20; 31(9):1239-47. View Abstract
  35. Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group. J Clin Oncol. 2012 Sep 20; 30(27):3408-16. View Abstract
  36. The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2011 Dec 01; 57(6):1062-6. View Abstract
  37. Health status of the oldest adult survivors of cancer during childhood. Cancer. 2010 Jan 15; 116(2):497-505. View Abstract
  38. Secondary malignancies across the age spectrum. Semin Radiat Oncol. 2010 Jan; 20(1):67-78. View Abstract
  39. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol. 2009 Aug 20; 27(24):3901-7. View Abstract
  40. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004 Oct 19; 141(8):590-7. View Abstract
  41. [Primary T-cell pulmonary lymphoma. A case report and review of the literature]. Arch Bronconeumol. 2002 Dec; 38(12):596-8. View Abstract
  42. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001 Feb 01; 91(3):613-21. View Abstract
  43. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion. 2001 Feb; 41(2):264-8. View Abstract
  44. Increased incidence of cancer in infants in the U.S.: 1980-1990. Cancer. 1998 Apr 01; 82(7):1396-400. View Abstract
  45. Birth defects in offspring of adult survivors of childhood acute lymphoblastic leukemia. A Childrens Cancer Group/National Institutes of Health Report. Cancer. 1996 Jul 01; 78(1):169-76. View Abstract

Contact Lisa Kenney

Print Profile